Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ACOR - Acorda Therapeutics Non-GAAP EPS of -$3.15 revenue of $31.05M

ACOR - Acorda Therapeutics Non-GAAP EPS of -$3.15 revenue of $31.05M

Acorda Therapeutics Inc.
  • Acorda Therapeutics press release ( NASDAQ: ACOR ): Q2 Non-GAAP EPS of -$3.15.
  • Revenue of $31.05M (-2.3% Y/Y).
  • For the full year 2022, Acorda continues to expect AMPYRA net revenue to be $68 – $78 million, and operating expenses to be $110 – $120 million. The operating expense guidance is a non-GAAP projection that excludes restructuring costs and share-based compensation as more fully described below under “Non-GAAP Financial Measures.”

For further details see:

Acorda Therapeutics Non-GAAP EPS of -$3.15, revenue of $31.05M
Stock Information
Company Name: Acorda Therapeutics Inc.
Stock Symbol: ACOR
Market: NASDAQ
Website: acorda.com
Menu
ACOR ACOR Quote ACOR Short ACOR News ACOR Articles ACOR Message Board
Get ACOR Alerts

News, Short Squeeze, Breakout and More Instantly...